A Comparison of Topical Nepafenac to Placebo in Corneal Epithelial Healing Times and Postoperative Pain Relief
Photorefractive Keratectomy
About this trial
This is an interventional treatment trial for Photorefractive Keratectomy focused on measuring Photorefractive Keratectomy
Eligibility Criteria
Inclusion Criteria: 19 years or older with healthy ocular status and pre-operative refractive anisometropia of less than 2.000 diopters between eyes undergoing bilateral PRK surgery. Other protocol-defined inclusion criteria may apply. Exclusion Criteria: Those desiring PRK in only one eye, those in need of additional topical eye medications, those with history of drug/alcohol abuse, women breastfeeding or pregnant. Other protocol-defined exclusion criteria may apply.
Sites / Locations
- Lackland Air Force Base
Arms of the Study
Arm 1
Arm 2
Experimental
Placebo Comparator
Nevanac
Acular LS
One drop, three times daily, in the assigned eye for the first three postoperative days
One drop, three times daily, in the assigned eye for the first three postoperative days